Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

miR34a in pcDNA3.1 Citations (2)

Originally described in: Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients.
Eichelser C, Stuckrath I, Muller V, Milde-Langosch K, Wikman H, Pantel K, Schwarzenbach H Oncotarget. 2014 Oct 30;5(20):9650-63.
PubMed Journal

Articles Citing miR34a in pcDNA3.1

Articles
Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA. Richardson CD, Ray GJ, DeWitt MA, Curie GL, Corn JE. Nat Biotechnol. 2016 Jan 20. doi: 10.1038/nbt.3481. PubMed

Associated Plasmids

Apoptosis-targeted gene therapy for non-small cell lung cancer using chitosan-poly-lactic-co-glycolic acid -based nano-delivery system and CASP8 and miRs 29A-B1 and 34A. Chattopadhyay S, Sarkar SS, Saproo S, Yadav S, Antil D, Das B, Naidu S. Front Bioeng Biotechnol. 2023 Jun 6;11:1188652. doi: 10.3389/fbioe.2023.1188652. eCollection 2023. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.